Water, Air, & Soil Pollution

, 224:1770 | Cite as

A Review of Pharmaceuticals and Endocrine-Disrupting Compounds: Sources, Effects, Removal, and Detections

  • Jimoh O. Tijani
  • Ojo O. Fatoba
  • Leslie. F. Petrik
Article

Abstract

There are growing concerns about the increasing trends of emerging micropollutants in the environment due to their potential negative impacts on natural ecosystems and humans. This has attracted attention from both governmental and non-governmental organisations worldwide. Pharmaceuticals, personal care products, and endocrine disruptors are continuously being released consciously or unconsciously into water sources due to poor regulatory frameworks especially in the developing countries. The effects of these contaminants are poorly known. They are not easily biodegradable and have become an environmental nuisance and public health issue. This has heightened the risk of exposure to their deleterious effects in such countries where the majority of the population are still struggling to have access to good quality drinking water supplies and better sanitation. With the rising fear of short- and long-term impacts of the ever-increasing number of persistent recalcitrant organic compounds accumulating in the environment, their removal is gradually becoming an issue to the water treatment industry. Hence, there is a need to develop functional techniques for the management of water contaminated by these emerging contaminants so as to increase the availability and access to safe and good-quality drinking water. We conducted a narrative review on these emerging micropollutants and examined their various documented sources, effects, as well as recent techniques for their effective removal. This becomes necessary due to the increasing occurrence of these pollutants in the aquatic and terrestrial environment. These levels are expected to further increase in the coming years as a consequence of the ever-increasing population density which undoubtedly characterizes developing economies. Our findings show that the present reported treatment techniques in the literature such as biological oxidation/biodegradation, coagulation/flocculation, ozonation, electrodialysis, reverse osmosis, sedimentation, filtration, and activated carbon were not designed for removal of these newly identified contaminants, and as such, the techniques are not sufficient and unable to completely degrade the compounds. We therefore recommended the need for concerted efforts to develop better techniques, especially combined advanced oxidative methods to address the shortcomings of and growing challenge to current practices.

Keywords

Pharmaceutical and personal care products Endocrine disrupting compounds Coagulation/flocculation Ozonation Electrodialysis Reverse osmosis Sedimentation Filtration Activated carbon Advanced oxidation process 

References

  1. Ali Nickheslat., Mohammad Mehdi Amin, Hassan Izanloo, Ali Fatehizadeh, & Seyed Mohammad Mousavi. (2013). Phenol Photocatalytic Degradation by Advanced Oxidation Process under Ultraviolet Radiation Using Titanium Dioxide. Journal of Environmental and Public Health, Volume 2013 (2013), Article ID 815310, 9 pagesGoogle Scholar
  2. Al-Rifai, J. H., Khabbaz, H., & Schäfer, A. I. (2011). Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems. Separation and Purification Technology, 77, 60–67.Google Scholar
  3. Andersson, A. M., Jensen, T. K., Juul, A., Petersen, J. H., Jorgensen, T., & Skakkebaek, N. E. (2007). Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. Journal of Clinical Endocrinology and Metabolism, 92, 4696–4705.Google Scholar
  4. Andreozzi, R., Caprio, V., Marotta, R., & Vogna, D. (2003a). Paracetamol oxidation from aqueous solutions by means of ozonation and H2O2/UV system. Water Research, 37, 993–1004.Google Scholar
  5. Andreozzi, R., Caprio, V., Marotta, R., & Radovnikovic, A. (2003b). Ozonation and H2O2/UV treatment of clofibric acid in water: A kinetic investigation. Journal of Hazardous Materials, 103, 233–246.Google Scholar
  6. Ankley, G. T., Brooks, B. W., Huggett, D. B., & Sumpter, J. P. (2007). Repeating history: Pharmaceuticals in the environment. Environmental Science and Technology, 41, 8211–8217.Google Scholar
  7. Ashiya, B., & Guatam, S. K. (2011). Application of Photocatalysis for the degradation of Endocrine disrupting chemicals: Endosulphan and lindane. IJEP, 31(8), 658–665.Google Scholar
  8. Ashton, D., Hilton, M., & Thomas, K. V. (2004). Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Science of the Total Environment, 333, 167–184. doi:10.1016/j.scitotenv.2004.04.062.Google Scholar
  9. Assmuth, T., & Louekari, K. (2001). Research for management of environmental risks from endocrine disrupters – contexts, knowledge base, methodologies and strategies. Helsinki: Finnish Environment Institute.Google Scholar
  10. Badawy, M. I., Wahaab, R. A., & El-Kalliny, A. S. (2009). Fenton-biological treatment processes for the removal of some pharmaceuticals from industrial wastewater. Journal of Hazardous Materials, 167, 567–574.Google Scholar
  11. Barnes, K.K., Kolpin, D.W., Meyer, M.T., Thurman, E.M., Furlong, E.T and Zaugg, S.D (2002). Water quality data for pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000. United States Geological Survey.Google Scholar
  12. Barnhoorn, I. E. J., Bornman, M. S., Pieterssse, G. M., & Vuren, J. H. J. (2004). Histological evidence of intersex in feral sharptooth catfish (Clarias gariepinus) from an estrogen-polluted water source in Gauteng, South Africa. Environmental Toxicology, 19, 603–608.Google Scholar
  13. Belgiorno, V., Rizzo, L., Fatta, D., Rocca, C. D., Lofrano, G., Nikolaou, A., Naddeo, V., & Meric, S. (2007). Review on endocrine disrupting-emerging compounds in urban wastewater: Occurrence and removal by photocatalysis and ultrasonic irradiation for wastewater reuse. Desalination, 215, 166–176.Google Scholar
  14. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Standford, B. D., & Snyder, S. A. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science and Technology, 43, 597–603.Google Scholar
  15. Besse, J. P., & Garric, J. (2009). Progestagens for human use, exposure and hazard assessment for the aquatic environment. Environ Pollution, 157, 3485–3494.Google Scholar
  16. Besse, J. P., Kausch Barreto, C., & Garric, J. (2008). Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritization. J Human Ecol Ris Assess, 14(4), 665–695.Google Scholar
  17. Besse, J. P., Latour, J. F., & Garric, J. (2012). Anticancer drugs in surface waters. What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environmental International, 39, 73–86.Google Scholar
  18. Bisceglia, K.J. & Roberts, A.L. (2006). A usage study and preliminary environmental risk assessment for human pharmaceuticals in the United States. Environ. Sci. Technol., in preparation.Google Scholar
  19. Blazkova, M., Mickova-Holubova, B., Rauch, P., & Fukal, L. (2009). Immunochromatographic colloidal carbon-based assay for detection of methiocarb in surface water. Biosensors and Bioelectronics, 25(4), 753–758.Google Scholar
  20. Bolong, N., Ismail, A. F., Salim, M. R., & Matsuura, T. (2009). A review of the effects of emerging contaminants in wastewater and options for their removal. Desalination, 239, 229–246.Google Scholar
  21. Bonefeld-Jorgensen, E. C., Long, M., Hofmeister, M. V., & Vinggaard, A. M. (2007). Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: New data and a brief review. Environmental Health Perspectives, 115(Suppl. 1), 69–76.Google Scholar
  22. Bound, J. P., & Voulvoulis, N. (2005). Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ. Health Perspectives, 113, 1705–1711.Google Scholar
  23. Boxall, A. B. A., Fogg, L. A., Blackwell, P. A., Kay, P., Pemberton, E. J., & Croxford, A. (2004). Veterinary medicines in the environment. Reviews of Environmental Contamination and Toxicology, 180, 1–91.Google Scholar
  24. Boyd, G. R., Reemtsma, H., Grimm, D. A., & Mitra, S. (2003). Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Science of the Total Environment, 311, 135–149.Google Scholar
  25. Braga, O., Smythe, G. A., Schafer, A. I., & Feitz, A. J. (2005). Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environmental Science Technology 39, 3351–3358.Google Scholar
  26. Brausch, J. M., & Rand, G. M. (2011). A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere, 82, 1518–1532.Google Scholar
  27. Brooks, B. W., Riley, T. M., & Taylor, R. D. (2006). Water quality of effluent-dominated stream ecosystems: Ecotoxicological, hydrological, and management considerations. Hydrobiologia, 556, 365–379.Google Scholar
  28. Burkhardt-Holm, P., Giger, W., Güttinger, H., Ochsenbein, U., Peter, A., Scheurer, K., Suter, M. J. F., Ochsenbein, U., Segner, H., & Staub, E. (2005). Where have all the fish gone. Environmental Science and Technology, 39, 441A–447A.Google Scholar
  29. Caliman, F. A., & Gavrilescu, M. (2009). Pharmaceuticals, personal care products and endocrine disrupting agents in the environment – a review. Clean, 37(4–5), 277–303.Google Scholar
  30. Campbell, C. G., Borglin, S. E., Green, F. B., Grason, A., Wozei, E., & Stringfellow, W. T. (2006). Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water: A review. Chemosphere, 65, 1265–1280.Google Scholar
  31. Carballa, M., Omil, F., Lema, J. M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M., & Ternes, T. (2004). Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research, 38, 2918–2926.Google Scholar
  32. Carballa, M., Manterola, G., Larrea, L., Ternes, T., Omil, F., & Lema, J. M. (2007). Influence of ozone pretreatment on sludge anaerobic digestion: Removal of pharmaceutical and personal care products. Chemosphere, 67, 1444–1452.Google Scholar
  33. Chatzitakis, A., Berberidou, C., Paspaltsis, I., Kyriakou, G., Sklaviadis, T., & Poulios, I. (2008). Photocatalytic degradation and drug activity reduction of chloramphenicol. Water Research, 42, 386–394.Google Scholar
  34. Chong, M. N., & Jin, B. (2012). Photocatalytic treatment of high concentration carbamazepine in synthetic hospital wastewater. Journal of Hazardous Materials, 199–200, 135–142.Google Scholar
  35. Chong, M. N., Jin, B., Laera, G., & Christopher, P. S. (2011). Evaluating the photodegradation of Carbamazepine in a sequential batch photoreactor system: Impacts of effluent organic matter and inorganic ions. Chemical Engineering Journal, 174, 595–602.Google Scholar
  36. Chong, M.N., Laera, G. & Jin, B. (2012). Integrating membrane bioreactor with advanced TiO2 photocatalytic technology for the removal of pharmaceutical drugs from recycled wastewater. 9 th IWA Leading-Edge Conference on Water and Wastewater Technologies.Google Scholar
  37. Coleman, H. M., Routledge, E. J., Sumpter, J. P., Eggins, B. R., & Byrne, J. A. (2004). Rapid loss of estrogenicity of steroid estrogens by UVA photolysis and photocatalysis over an immobilized titanium dioxide catalyst. Water Research, 38, 3233–3240.Google Scholar
  38. Comerton, A. M., Andrews, R. C. & Bagley, D. M. (2009). Practical overview of analytical methods for endocrine disrupting compounds, pharmaceuticals and personal care products in water and wastewater. Philosophical Transactions of Royal Society A, 367(1904), 3923–3939.Google Scholar
  39. Cortés Muñoz, J.E., Calderón Mólgora, G.C., Martín Domínguez, A., Espino de la O, E.E. Gelover Santiago, S.L., Hernández Martínez, C.L., Moeller Chávez, G.E. (2013). Endocrine disruptors in water sources: Human health risks a, INTECH Publisher (pp 1)Google Scholar
  40. Czech Bozena and Rubinowska Katarzyna. (2013). TiO2-assisted photocatalytic degradation of diclofenac, metoprolol, estrone and chloramphenicol as endocrine disruptors in water. Adsorption, 19, 619–630.Google Scholar
  41. Daughton, C. G. (2002). Environmental stewardship and drugs as pollutants. Lancet, 360, 1035–1036.Google Scholar
  42. Daughton, C. G. (2004). Non-regulated water contaminants: Emerging research. Environmental Impact Assessment Review, 24(7–8), 711–732.Google Scholar
  43. Daughton, C. G., & Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107, 907–938.Google Scholar
  44. Davies, L., & Welch, H. G. (2006). Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 295, 2164–2167.Google Scholar
  45. Diamanti-Kandarakis, E., Bourguignon, J. P., & Giudice, L. C. (2009). Endocrine disrupting chemicals: An Endocrine Society scientific statement. Endocrine Reviews, 30, 293–342.Google Scholar
  46. Dixit, A., Mungray, A. K., & Chakraborty, M. (2010). Photochemical oxidation of phenol and chlorophenol by UV/H2O2/TiO2 process: A kinetic study. International Journal of Chemical Engineering and Applications, 1(3), 247–250.Google Scholar
  47. Doll, T. E., & Frimmel, F. H. (2004). Kinetic study of photocatalytic degradation of carbamazepine, clofibric acid, iomeprol and iopromide assisted by different TiO2 materials determination of intermediates and reaction pathways. Water Research, 38, 955–964.Google Scholar
  48. Ellis, J. B. (2006). Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environm. Poll, 144, 184–189.Google Scholar
  49. Enewold, L., Zhu, K., & Ron, E. (2009). Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiology, Biomarkers and Prevention, 18, 784–791.Google Scholar
  50. Esmaeli, R., Hassani, A. H., Eslami, A., Ahmadi Moghadam, M., & Safari, A. A. (2011). Di-(2-ethylhexyl) phthalate oxidative degradation by Fenton process in synthetic and real petrochemical wastewater. Iran. J. Environ. Health. Sci. Eng., 8(3), 201–206.Google Scholar
  51. Esplugas, S., Bila, D. M., Krause, L. G. T., & Dezotti, M. (2007). Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. Journal of Hazardous Materials, 149(3), 631–642.Google Scholar
  52. Fabiola, M.-A., Gimenez, J., & Esplugas, S. (2008). Photolysis and TiO2 photocatalytic treatment of naproxen: Degradation, mineralization, intermediates and toxicity. J. Adv. Oxid. Technol, 11(3), 436–445.Google Scholar
  53. Falconer, I. R., Chapman, H. F., Moore, M. R., & Ranmuthugala, G. (2006). Endocrine-disrupting compounds: A review of their challenge to sustainable and safe water supply and water reuse. Environmental Toxicology, 21, 181–191.Google Scholar
  54. Farré, M., Kantiani, L., Perez, S., & Barcelo, D. (2009). Sensors and biosensors in support of EU Directives. Trends in Analytical Chemistry, 28(2), 170–185.Google Scholar
  55. Fatoki, O. S., & Opeolu, B. O. (2009). Studies on the occurrence and quantification of phenolic endocrine disruptors in water. Scientific Research and Essay, 4(12), 1415–1422.Google Scholar
  56. Fawell, J., & Ong, C. N. (2012). Emerging contaminants and the implications for drinking water. International Journal of Water Resources Development, 28(2), 247–263.Google Scholar
  57. Fent, K., Weston, A. A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122–159.Google Scholar
  58. Ferraz, N., Carnevi Nande, G., Rossotti, M., Miguez, M. N., Last, J. A., & Gonzalez-Sapienza, G. (2007). Specific immunoassays for endocrine disruptomonitoring using recombinant antigens cloned by degenerated primePCR. Analytical and Bioanalytical Chemistry, 389, 2195–2202.Google Scholar
  59. Fick, J., Soderstrom, H., Lindberg, R. H., Phan, C., Tysklind, M., & Larsson, D. G. J. (2009). Contamination of surface, ground, and drinking water from pharmaceutical production. Environmental Toxicology and Chemistry, 28, 2522–2527.Google Scholar
  60. Flint, S., Markle, T., Thompson, S., & Wallace, E. (2012). Bisphenol A exposure, effects, and policy: A wildlife perspective. Journal of Environmental Management, 104, 19–34.Google Scholar
  61. Focazio, M. J., Kolpin, D. W., Barnes, K. K., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Barber, L. B., & Thurman, M. E. (2008). A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States—II) Untreated drinking water sources. Science of the Total Environment, 402, 201–216.Google Scholar
  62. Friedmann, D., Mendive, C., & Bahnemann, D. (2010). TiO2 for water treatment: parameters affecting the kinetics and mechanisms, of photocatalysis. Applied Catalysis B, 99, 398–406.Google Scholar
  63. Frontistis, Z., Daskalaki, V. M., Hapeshi, E., Drosou, C., Fatta-Kassinos, D., Xekoukoulotakis, N. P., & Mantzavinos, D. (2012). Photocatalytic (UV-A/TiO2) degradation of 17α-ethynylestradiol in environmental matrices: Experimental studies and artificial neural network modelling. Journal of Photochemistry and Photobiology A: Chemistry, 240, 33–41.Google Scholar
  64. Game, C., Gagnon, M. M., Webb, D., & Lim, R. (2006). Endocrine disruption in male mosquitofish (Gambusia holbrooki) inhabiting wetlands in Western Australian. Ecotoxicol., 15, 665–672.Google Scholar
  65. Garric, J., & Ferrari, B. (2005). Pharmaceuticals in aquatic ecosystems. Levels of exposure and biological effects: A review. Revue des sciences de l’eau, 18, 307–330.Google Scholar
  66. Gatidou, G., Thomaidis, N., Stasinakis, A., & Lekkas, T. (2007). Simultaneous determination of the endocrine disrupting compounds nonylphenol, nonylphenol ethoxylates, triclosan and bisphenol A in wastewater and sewage sludge by gas chromatography–mass spectrometry. Journal of Chromatography A, 1138(1–2), 32–41.Google Scholar
  67. Giri, R. R., Ozaki, H., Ota, S., Takanami, R., & Taniguchi, S. (2010). Degradation of common pharmaceuticals and personal care products in mixed solutions by advanced oxidation techniques. Int. J. Environ. Sci. Tech., 7(2), 251–260.Google Scholar
  68. Glassmeyer, S. T., Furlorg, E. T., Kolpin, D. W., Cahill, J. D., Zuagg, S. D., Werner, S. L., Meyer, M. T., & Kryak, D. D. (2005). Transports of chemicals and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination. Environmental Science and Technology, 39, 5157–5169.Google Scholar
  69. Gogate, P. R., & Pandit, A. B. (2004). A review of imperative technologies for wastewater. Chemosphere, 73, 848–853.Google Scholar
  70. Gulkowska, A., Leung, H. W., So, M. K., Taniyasu, S., Yamashita, N., Yeung, L. W. Y., Richardson, B. J., Lei, A. P., Giesy, J. P., & Lam, P. K. S. (2008). Removal of antibiotics from wastewater by sewage treatment facilities in Hongkong and Shenzhen, China. Water Research, 42(1–2), 395–403.Google Scholar
  71. Gunnarsson, L., Adolfsson-Erici, M., Björlenius, B., Rutgersson, C., Förlin, L., & Larsson, D. G. J. (2009). Comparison of six different sewage treatment processes—reduction of estrogenicsubstances and effects on gene expression in exposed male fish. Science of the Total Environment, 407, 5235–5242.Google Scholar
  72. Ha, M. H., Lee, D. H., & Jacobs, D. R. (2007). Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: Results from the National Health and Nutrition Examination Survey, 1999–2002. Environmental Health Perspectives, 115, 1204–1209.Google Scholar
  73. Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., & Jørgensen, S. E. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment–a review. Chemosphere, 36(2), 357–393.Google Scholar
  74. Harrison, P. T. C. (2001). Endocrine disrupters and human health. Brit. Med. J., 323, 1317–1318.Google Scholar
  75. Harrison, E. Z., Oakes, S. R., Hysell, M., & Hay, A. (2006). Organic chemicals in sewage sludges. Science of the Total Environment, 367, 481–497.Google Scholar
  76. Hartmann, J., Bartels, P., Mau, U., Witter, M., Tumpling, W. V., & Hofmann, J. (2008). Degradation of the drug diclofenac in water by sonolysis in presence of catalyst. Chemosphere, 70, 453–461.Google Scholar
  77. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicology Letters, 131, 5–17.Google Scholar
  78. Heberer, T., & Feldman, D. (2005). Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluent modelling versus measurement. J.Hazardous Materials, 122, 211–218.Google Scholar
  79. Hecker, M., & Giesy, J. P. (2008). Novel trends in endocrine disrupting testing: The H295R steroidogenesis assay for identification of inducers and inhibitors of hormone production. Analytical and Bioanalytical Chemistry, 390, 287–291.Google Scholar
  80. Hileman, B. (2005). Antiseptic soaps under scrutiny: FDA to assess whether household use leads to bacterial resistance. Chemical and Engineering News, 83, 14.Google Scholar
  81. Hill, S. S., Shawa, B. R., & Wuc, A. H. B. (2001). The clinical effects of plasticizers, antioxidants, and other contaminants in medicapolyvinylchloride tubing during respiratory and non-respiratoexposure. Review. Clin. Chim. Acta, 304, 1–8.Google Scholar
  82. Houeto, P., Carton, A., Guerbet, M., Mauclaire, A. C., Gatignol, C., & Lechat, P. (2012). Assessment of the health risks related to the presence of drug residues in water for human consumption: Application to carbamazepine. Regul Toxicol Pharm, 62(1), 41–48.Google Scholar
  83. Houtman, C. J. (2010). Emerging contaminants in surface water and their relevance for the production of drinking water in Europe. Journal of Integrative Environmental Sciences, 7(4), 271–295.Google Scholar
  84. Hu, A., Zhang, X., Luong, D. Oakes, K. D. Servos, M. R. Liang, R. Kurdi, S. Peng, P. & Zhou, Y. (2012). Adsorption and Photocatalytic Degradation Kinetics of Pharmaceuticals by TiO2 Nanowires During Water Treatment. Waste Biomass Valor.Google Scholar
  85. Huang, P. C., Tien, C. J., Sun, Y. M., Hsieh, C. Y., & Lee, C. C. (2008). Occurrence of Phthalates in sediment and biota: Relationship to aquatic factors and the biota-sediment accumulation factor. Chemosphere, 73, 539–544.Google Scholar
  86. Huertas-Perez, J. F., & Garcia-Campana, A. M. (2008). Determination of N-methylcarbamate pesticides in water and vegetable samples by HPLC with postcolumn chemiluminescence detection using the luminol reaction. Analytica Chimica Acta, 630(2), 194–204.Google Scholar
  87. Huyghe, E., Matsuda, T., & Thonneau, P. (2003). Increasing incidence of testicular cancer worldwide: A review. Journal of Urology, 170, 5–11.Google Scholar
  88. Iwuoha, E. I. (2012). Smart nano-dimensional dendritic aptasensor for real-time determination of estrogenic 17β-estradiol. International conference and exhibition on biosensors and bioelectronics. May 14–16, 2012 Embassy Suites Las Vegas, USA.Google Scholar
  89. Jackson, J., & Sutton, R. (2008). Sources of endocrine-disrupting chemicals in urban wastewater, Oakland, CA. Science of the Total Environment, 405, 153–160.Google Scholar
  90. Janex-Habibi, M. L., Bruchet, A., & Ternes, T. A. (2004). Effect of drinking water treatment and waste water treatment on drug residues. Results of the Poseidon Project. Techniques, Sciences, Methods, 11, 59–67.Google Scholar
  91. Jiao, B., & Cheng, C. H. K. (2008). Disruption actions of bisphenol A and malachite green on growth hormone receptor gene expression and signal transduction in seabream. Fish Physiology and Biochemistry, 36(2), 251–261.Google Scholar
  92. Jin, X. L., Jiang, G. B., Huang, G. L., Liu, J. F., & Zhou, Q. F. (2004). Determination of 4-tert-octylphenol, 4-nonylphenol and bisphenol A in surface waters from the Haihe River in Tianjin by gas chromatography–mass spectrometry with selected ion monitoring. Chemosphere, 56(11), 1113–1119.Google Scholar
  93. Johnson, D. M., Hokanson, D. R., Zhang, Q., Czupinski, K. D., & Tang, J. (2008). Feasibility of water purification technology in rural areas of developing countries. Journal of Environmental Management, 88, 416–427.Google Scholar
  94. Jones-Lepp, T. L., & Stevens, R. (2007). Pharmecuticals and personal care products in biosolids/sewage sludge: The interface between analytical chemistry and regulation. Analytical and Bioanalytical Chemistry, 387, 1173.Google Scholar
  95. José, H. J., Gebhardt, W., Moreira, R. F. P. M., Pinnekamp, J., & Schröder, H. F. (2010). Advanced oxidation processes for the elimination of drugs resisting biological membrane treatment. Ozone: Science & Engineering, 32, 305–312.Google Scholar
  96. Joseph, L., Heo, J., Park, Y.-G., Flora, J. R. V., & Yoon, Y. (2011). Adsorption of bisphenol A and 17α-ethinyl estradiol on single walled carbon nanotubes from seawater and brackish water. Deslination, 281, 68–74.Google Scholar
  97. Kasprzyk-Hordern, B., Dinsdale, R. M., & Guwy, A. J. (2009). The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research, 43(2), 363–380.Google Scholar
  98. Kidd, K. A., Blanchfield, P. J., Mills, K. H., Palace, V. P., Evans, R. E., Lazorchak, J. M., & Flick, R. W. (2007). Collapse of a fish population after exposure to a synthetic estrogen. Proceeding of the National Academy of Sciences, 104, 8897–8901.Google Scholar
  99. Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., & Snyder, S. A. (2007). Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters. Water Research, 41, 1013–1021.Google Scholar
  100. Kim, I., Yamashita, N., & Tanaka, H. (2009). Photodegradation of pharmaceuticals and personal care products during UV and UV/H2O2 treatments. Chemosphere, 77, 518–525.Google Scholar
  101. Kinney, C. A., Furlong, E. T., Kolpin, D. W., Burkhardt, M. R., Zaugg, S. D., Werner, S. L., Bossio, J. P., & Benotti, M. J. (2008). Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environmental Science & Technology, 42, 1863–1870.Google Scholar
  102. Klavarioti, M., Mantzavinos, D., & Kassinos, D. (2009). Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environment International, 35, 402–417.Google Scholar
  103. Klecka, G.M., Staples, C.A., Clark, K.E., Van der Hoeven, N., Thomas, D.E., & Hentges, S.G., (2009). Exposure analysis of bisphenol-A in surface water Systems North America and Europe. Environmental Science and Technology, 6145–6150.Google Scholar
  104. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., & Buxton, H. T. (2002). Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999–2000: A national reconnaissance. Environmental Science and Technology, 36, 1202–1211.Google Scholar
  105. Kümmerer, K., & Al-Ahmad, A. (2010). Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environmental Science and Pollution Research, 17, 486–496.Google Scholar
  106. Lafi, W.K., & Al-Qodah, Z. (2006). Combined advanced oxidation and biological treatment processes for the removal of pesticides from aqueous solutions. Journal of Hazardous Materials, B137: 489:49.Google Scholar
  107. Larsen, T. A., Lienert, J., Joss, A., & Siegrist, H. (2004). How to avoid pharmaceuticals in the aquatic environment. Journal of Biotechnology, 113, 295–304.Google Scholar
  108. Larsson, D. G. J., de Pedro, C., & Paxeus, N. (2007). Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazardous Materials, 148, 751–755.Google Scholar
  109. Le Blanc, F. A., Albrecht, C., Bonn, T., Fechner, P., Proll, G., Pro¨, F., II, Carlquist, M., & Gauglitz, G. (2009). A novel analytical tool for quantification of estrogenicity in river water based on fluorescence labelled estrogen receptor a. Analytical and Bioanalytical Chemistry, 395(6), 1769–1776.Google Scholar
  110. Lear, J. C., Maillard, J. Y., Dettmar, P. W., Goddard, P. A., & Russell, A. D. (2002). Chloroxylenol- and triclosan-tolerant bacteria from industrial sources. Journal of Industrial Microbiology and Biotechnology, 29, 238–242.Google Scholar
  111. Lee, L. S., Strock, T. J., Sarmah, A. K., & Rao, P. S. C. (2003). Sorption and dissipation of testosterone, estrogens, and their primary transformation products in soils and sediment. Environmental Science and Technology, 37, 4098–4105.Google Scholar
  112. Li, Y., Niu, J., Yin, L., Wang, W., Bao, Y., Chen, J., & Duan, Y. (2011). Photocatalytic degradation kinetics and mechanism of pentachlorophenol based on superoxide radicals. Journal of Environmental Sciences, 23(11), 1911–1918.Google Scholar
  113. Lin, A. Y. C., Yu, T. H., & Lin, C. F. (2008). Pharmaceutical contamination in residential, industrial and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere, 74, 131.Google Scholar
  114. Lin, S., Didi, Y., Jingjing, L., & Tingting, Z. (2013). Study on the photocatalytic degradation characteristics of Ibuprofen with immobilized TiO2 catalyst. Journal of Nanjing Forestry University, 37(4), 90–94.Google Scholar
  115. Linden, K. G., Rosenfeldt, E. J., & Kullman, S. W. (2007). UV/H2O2 degradation of endocrine-disrupting chemicals in water evaluated via toxicity assays. Water Science and Technology, 55, 313–319.Google Scholar
  116. Lindqvist, N., Tuhkanen, T., & Kronberg, L. (2005). Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research, 39(11), 2219–2228.Google Scholar
  117. Lishman, L., Smyth, S. A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M., & Seto, P. (2006). Occurrence and reduction of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario. Canada. Sci. Total Environ., 367, 544–558.Google Scholar
  118. Liu, Z.-h., Kanjo, Y., & Mizutani, S. (2009). Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment — physical means, biodegradation, and chemical advanced oxidation: A review. Science of the Total Environment, 407, 731–748.Google Scholar
  119. Liu, Y., Guan, Y. T., Tam, N. F. Y., Mizuno, T., Tsuno, H., & Zhu, W. P. (2010). Influence of rainfall and basic water quality parameters on the distribution of endocrine-disrupting chemicals in coastal area. Water, Air, and Soil Pollution, 209, 333–343.Google Scholar
  120. Lopez, A., Anna, B., Giuseppe, M., & John, K. (2003). Kinetic investigation on UV and UV/ H2O2 degradations of pharmaceutical intermediates in aqueous solution. J. Photochem. Photobiol., 156, 121–126.Google Scholar
  121. Lyons, M. (2008). Is there something. In: The water?http://chicagoist.com/2008/04/17/is_there_someth.php. Accessed 5 Nov 2009).
  122. Machulek, Jr. A., Silvio C. Oliveira, Marly E. Osugi, Valdir S. Ferreira, Frank H. Quina, Renato F. Dantas, Samuel L. Oliveira, Gleison A. Casagrande, Fauze J. Anaissi, Volnir O. Silva, Rodrigo P. Cavalcante, Fabio Gozzi, Dayana D. Ramos, Ana P.P. da Rosa, Ana P.F. Santos, Douclasse C. de Castro, & Jéssica A. Nogueira. (2013). Application of Different Advanced Oxidation Processes for the Degradation of Organic Pollutants. Chapter 6, INTECH publisher Organic Pollutants - Monitoring, Risk and Treatment. Pp 142.Google Scholar
  123. Mackenzie, C. A., Lockridge, A., & Keith, M. (2005). Declining sex ratio in a first nation community. Environmental Health Perspectives, 113(10), 1295–1298.Google Scholar
  124. Madhavan, J., Grieser, F., & Ashokkumar, M. (2010). Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. Journal of Hazardous Materials, 178(1), 202–208.Google Scholar
  125. Maletz, S., Floehr, T., Beier, S., Klümper, C., Brouwer, A., Behnisch, P., Higley, E., Giesy, J. P., Heckerd, M., Gebhardt, W., Linnemann, V., Pinnekamp, J., & Hollert, H. (2013). In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents. Water Research, 47(4), 1545–1557.Google Scholar
  126. Mara, D. D. (2003). Water, sanitation and hygiene for the health of developing nations. Public Health, 452–456.Google Scholar
  127. Marchesini, G. R., Koopal, K., Meulenberg, E., Haasnoot, W., & Irth, H. (2007). Spreetabased biosensor assays for endocrine disruptors, Biosen. Bioelectron., 22(9–10), 1908–1915.Google Scholar
  128. Mastin, J. P. (2005). Environmental cardiovascular disease. Cardiovascular Toxicology, 5, 91–94.Google Scholar
  129. Matos T.A.F., Dias A.L.N., Reis A.D.P., Apolinário da Silva M.R., & Kondo M.M. (2012). Degradation of Abamectin Using the Photo-Fenton Process. International Journal of Chemical Engineering, Article ID 915724, 7 pages.Google Scholar
  130. Mauricio, R., Diniz, M., Petrovic, M., Amaral, L., Peres, I., Barcel, O. D., & Santana, F. (2006). A characterization of selected endocrine disruptor compounds in a Portuguese wastewater treatment plant. Environmental Monitoring and Assessment, 118, 75–87.Google Scholar
  131. McClellan, K., & Halden, R. U. (2010). Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Research, 44, 658–668.Google Scholar
  132. Mendez-Arriaga, F., Esplugas, S., & Gimenez, J. (2008). Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation. Water Research, 42, 585–594.Google Scholar
  133. Michael, J. (2001). Are problems with male reproductive health caused by endocrine disruption? Occup Med Educ, 58, 281–288Google Scholar
  134. Moder, M., Braun, P., Lange, F., Schrader, S., & Lorenz, W. (2007). Determination of endocrine disrupting compounds and acidic drugs in water by coupling of derivatization, gas chromatograph and negative chemical ionization mass spectrometry. Clean Air Soil Water, 35(5), 444–451.Google Scholar
  135. Moldovan, Z. (2006). Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere, 64, 1808–1817.Google Scholar
  136. Montgomery, M. A., & Elimelech, M. (2007). Water and sanitation in developing countries: Including health in the equation. Environmental Science and Technology, 41, 17–24.Google Scholar
  137. Moore, M., Gould, P., & Keary, B. S. (2003). Global urbanization and impact on health. International Journal of Hygiene and Environmental Health, 206, 269–278.Google Scholar
  138. Mottaleb, M. A., Usenko, S., O’Donnell, J. G., Ramirez, A. J., Brooks, B. W., & Chambliss, C. K. (2009). Gas chromatography–mass spectrometry screening methods for select UV filters, synthetic musks, alkylphenols, an antimicrobial agent, and an insect repellent in fish. Journal of Chromatography A, 1216(5), 815–823.Google Scholar
  139. Murray, T. J., Lea, R. G., Abramovich, D. R., Haites, N. E., & Fowler, P. A. (2001). Early Pregnancy. Biologie et Médecine, 5, 80–112.Google Scholar
  140. Naa, S., Ahnb, Y.-G., Cui, M., & Khim, J. (2012). Significant diethyl phthalate (DEP) degradation by combined advanced oxidation process in aqueous solution. Journal of Environmental Management, 101, 104–110.Google Scholar
  141. Nakada, N., Tanishima, T., Shinohara, H., Kiri, K., & Takada, H. (2006). Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research, 40(17), 3297–3303.Google Scholar
  142. Nakada, N., Shinohara, H., Murata, A., Kiri, K., Managaki, S., Sato, N., & Takada, H. (2007). Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Research, 41(19), 4373–4382.Google Scholar
  143. Nakashima, T., Ohko, Y., Kubota, Y., & Fujishima, A. (2003). Photocatalytic decomposition of estrogens in aquatic environment by reciprocating immersion of TiO2-modified polytetrafluoroethylene mesh sheets. Journal of Photochemistry and Photobiology, A: Chemistry, 160, 115–120.Google Scholar
  144. Nakonechnya, M., Ikehataa, K., & El-Dina, M. G. (2008). Kinetics of Estrone Ozone/Hydrogen Peroxide Advanced Oxidation Treatment. Ozone Science and Engineering, 30, 249–255.Google Scholar
  145. Naz, R. K. (2005). Endocrine disruptors: Effects on male and female reproductive systems Boca Raton. FL: CRC Press.Google Scholar
  146. Ning, B., Graham, N., Zhang, Y., Nakonechny, M., & El-Din, M. G. (2007). Degradation of Endocrine Disrupting Chemicals by Ozone/AOPs. Ozone Science and Engineering, 29, 153–176.Google Scholar
  147. Nowotny, N., Epp, B., vonSonntag, C., & Fahlenkamp, H. (2007). Quantification and modeling of the elimination behavior of ecologically problematic wastewater micropollutants by adsorption on powdered and granulated activated carbon. Environmental Science and Technology, 41(6), 2050–2055.Google Scholar
  148. Oller, I., Malato, S., Sánchez-Pérez, J. A., Gernjak, W., Maldonado, M. I., & Pérez-Estrada, L. A. (2007). A combined solar photocatalytic–biological field system for the mineralization of an industrial pollutant at pilot scale. Catalysis Today, 122, 150–159.Google Scholar
  149. Oller, I., Malato, S., & Sánchez-Pérez, J. A. (2011). Combination of advanced oxidation processes and biological treatments for wastewater decontamination—A review. Science of the Total Environment, 409, 4141–4166.Google Scholar
  150. Olujimi, O. O., Fatoki, O. S., Odendaal, J. P., & Okonkwo, J. O. (2010). Endocrine disrupting chemicals (phenol and phthalates) in the South African environment: A need for more monitoring. Review. Water SA, 36(5), 671–682.Google Scholar
  151. Ortiz de García, S., PintoPinto, G., García Encina, P., & Mata, R. I. (2013). Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Science of the Total Environment, 444, 451–465.Google Scholar
  152. Palace, V. P., Evans, R. E., Wautier, K. G., Mills, K. H., Blanchfield, P. J., & Park, B. J. (2009). Interspecies differences in biochemical, histopathological, and population responses in four wild fish species exposed to ethynylestradiol added to a whole lake. Canada J. Fish Aquat Sci, 66, 1920–1935.Google Scholar
  153. Peng, X., Yiyi, Y., Tang, C., Tan, J., Huang, Q., & Wang, Z. (2008). Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Science of the Total Environment, 397, 158–166.Google Scholar
  154. Pereira, V. J., Linden, K. G., & Weinberg, H. S. (2007). Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water. Water Research, 41, 4413–4423.Google Scholar
  155. Perez-Estrada, L. A., Malato, S., Gernjak, W., Aguera, A., Thurman, E. M., & Ferrer, I. (2005). Photo- Fenton degradation of diclofenac: Identification of main intermediates and degradation pathway. Environmental Science and Technology, 39, 8300–8306.Google Scholar
  156. Petrovic, M., Eljarrat, E., Lopez de Alda, M. J., & Barcelo, D. (2004). Endocrine disrupting compounds and other emerging contaminants in the environment: A survey on new monitoring strategies and occurrence data. Analytical and Bioanalytical Chemistry, 378, 549.Google Scholar
  157. Petrovic, M., Gonalez, S., & Barcelo, D. (2003). Analysis and removal of emerging contaminants in wastewater and drinking water. Trends in Analytical Chemistry, 22(10),685–696.Google Scholar
  158. Pryor, S. W., Hay, A. G., & Walker, L. P. (2002). Nonylphenol in anaerobically digested sewage sludge from New York State. Environmental Science and Technology, 36, 3678–3682.Google Scholar
  159. Qin, M., Yang, H., Chen, S., Xie, H., & Guan, J. (2012). Photochemical characteristics of diclofenac and its photooxidation of inclusion complexes with β-cyclodextrins. Quimica Nova, 35, 559–562.Google Scholar
  160. Rahman, M. F., Yanful, E. K., & Jasim, S. Y. (2009a). Occurrences of endocrine disrupting compounds and pharmaceuticals in the aquatic environment and their removal from drinking water: Challenges in the context of the developing world. Desalination, 248, 578–585.Google Scholar
  161. Rahman, M. F., Yanful, E. K., & Jasim, S. Y. (2009b). Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: Implications for the drinking water industry and global environmental health. Journal of Water and Health, 7(2), 224–243.Google Scholar
  162. Rajeswari, R., & Kanmani, S. (2009). TiO2-based heterogeneous photocatalytic treatment combined with ozonation for carbendazim degradation. Iran. J. Environ. Health. Sci. Eng., 6(2), 61–66.Google Scholar
  163. Rengaraj, S. & Li, X. Z. (2011). Photocatalytic degradation of Bisphenol A as an endocrine disruptor in aqueous suspension using Ag-TiO2 catalysts. (In press).Google Scholar
  164. Richardson, S. D., & Ternes, T. A. (2005). Water analysis: Emerging contaminants and current issues. Analytical Chemistry, 77, 3807–3838.Google Scholar
  165. Roberts, P. H., & Thomas, K. V. (2006). The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Science of the Total Environment, 356, 143–153.Google Scholar
  166. Rodriguez-Mozaz, S., Lopeéz de Alda, M. J., & Barcelo, D. (2006). Biosensors as useful tools for environmental analysis and monitoring. Analytical and Bioanalytical Chemistry, 386(4), 1025–1041.Google Scholar
  167. Rogers, J. A., Metz, L., & Wee Yong, V. (2013). Review: Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms. Molecular immunology, 53, 421–430.Google Scholar
  168. Rosal, R., Rodríguez, A., Perdigón-Meló, J. A., Petre, A., Roefer, P., Synder, S., Zegers, R. E., Rexing, D. J., & Fronk, J. L. (2010). Endocrine disrupting chemicals in a source water. J. Am.WaterWorks Assoc, 92, 52–58. 92.Google Scholar
  169. Rossnera, A., Snyder, S. A., & Knappe, D. R. U. (2009). Removal of emerging contaminants of concern by alternative adsorbents. Water Research, 43, 3787–3796.Google Scholar
  170. Safe, S. H. (2000). Endocrine disruption and human health-is there a problem? An update. Environmental Health Perspectives, 108(6), 487–493.Google Scholar
  171. Saien, J., & Khezrianjoo, S. (2008). Degradation of the fungicide carbendazim in aqueous solutions with UV/TiO2 process: Optimization, kinetics and toxicity studies. Journal of Hazardous Materials, 157, 269–276.Google Scholar
  172. Saien, J., & Soleymani, A. R. (2007). Degradation and mineralization of direct blue 71 in a circulating upflow reactor by UV/TiO2 process and employing a new method in kinetic study. Journal of Hazardous Materials, 144, 506–512.Google Scholar
  173. Saien, J., Ojaghloo, Z., Soleymani, A. R., & Rasoulifard, M. H. (2011). Homogeneous and heterogeneous AOPs for rapid degradation of Triton X-100 in aqueous media via UV light, nano titania hydrogen peroxide and potassium persulfate. Chemical Engineering Journal, 167, 172–182.Google Scholar
  174. Samir, K. K., Xie, B., Thompson, M. L., Sung, S. W., Ong, S. K., & Leeuvent, J. V. (2006). Fate, transport, and biodegradation of natural estrogens in the environment and engineered systems. Environmental Science and Technology, 40, 6537–6546.Google Scholar
  175. Schug, T. T., Janesick, A., Blumberg, B., & Heindel, J. J. (2011). Endocrine disrupting chemicals and disease susceptibility. The Journal of Steroid Biochemistry and Molecular Biology, 127, 204–215.Google Scholar
  176. Segner, H. (2005). Developmental, reproductive, and demographic alterations in aquatic wildlife: Establishing causality between exposure to endocrine-active compounds (EACs) and effects. Acta Hydrochem. Hydrobiol., 33(1), 17–26.Google Scholar
  177. Sellin, M. K., Snow, D. D., Schwarz, M., Carter, B. J., & Kolok, A. S. (2009). Agrichemicals in Nebraska, USA, watersheds: Occurrence and endocrine effects. Environmental Toxicology and Chemistry/SETAC, 28, 2443–2448.Google Scholar
  178. Shannon, M. A., Bohn, P. W., Elimelech, M., Georgiadis, J. G., Mariňas, B. J., & Mayes, A. M. (2008). Science and techonology for water purification in the coming decades. Nature, 452(20), 301–310.Google Scholar
  179. Sharpe, R. M., & Irvine, D. S. (2004). How strong is the evidence of a link between environmental chemicals and adverse effects on human health? Brit. Med. J., 328, 447–451.Google Scholar
  180. Shemer, H., Kunukcu, Y. K., & Linden, K. G. (2006). Degradation of the pharmaceutical metronidazole via UV, Fenton and photo-Fenton processes. Chemosphere, 63, 269–276.Google Scholar
  181. Shin, J., Moon, H. J., Kang, H., Kim, T. S., Lee, S. J., Alin, J. Y., Bae, H., Jeung, E. B., & Han, S. Y. (2007). OECD validation of the rodent Hershberger assay using three reference chemicals 17 α-methyltestorone, procymidore and PP-DDE. Archives of Toxicology, 81, 309–318.Google Scholar
  182. Sin, J.-C., Lam, S.-M., Mohamed, A. R., & Lee, K.-T. (2012). Degrading endocrine disrupting chemicals from wastewater by TiO2 photocatalysis: A review. International Journal of Photoenergy, 185159, 1–23.Google Scholar
  183. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., Decarolis, J., Oppenheimer, J., Wert, E. C., & Yoon, Y. (2006). Role of membranes and activated carbon removal of endocrine disruptors and pharmaceuticals. Desalination, 202, 156–181.Google Scholar
  184. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., DeCarolis, J., Oppenheimer, J., Wert, E. C., & Yoon, Y. (2007). Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination, 202(1–3), 156–181.Google Scholar
  185. Stasinakis, A. S. (2008) Use of selected advanced oxidation processes (AOPs) for wastewater treatment – a mini review. Water and Air Quality Laboratory, Department of Environment University of the Aegean, University Hill, Mytilene 81100, Greece.Google Scholar
  186. Strauch, K. A. (2011). The impact of pharmaceuticals in the water supply. AAOHN Journal, 59(12), 525–532.Google Scholar
  187. Suarez, S., Carballa, M., Omil, F., & Lema, J. M. (2008). How are Pharmaceutical and Personal Care Compounds Removed from Urban Wastewaters. Reviews in Environmental Science and Biotechnology, 7, 125.Google Scholar
  188. Sui, Q., Huang, J., Deng, S., Gang, Y., & Fan, Q. (2010). Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Research, 44, 417–426.Google Scholar
  189. Sumpter, J. P. (2005). Endocrine disruptor in the aquatic environment: A review. Acta Hydrochem. Hydrobiol., 33(1), 9–16.Google Scholar
  190. Swaminathan, M., Muruganandham M., & Sillanpaa, M. (2013). advanced oxidation processes for wastewater treatment. International Journal of Photoenergy, Article ID 683682, 3 pages.Google Scholar
  191. Swan, S. H., Elkin, E. P., & Fenster, L. (2000). The question of declining sperm density revisited: An analysis of 101 studies published 1934–1996. Environmental Health Perspectives, 108, 961–966.Google Scholar
  192. Swati, M., Rema, T., & Joseph, K. (2008). Hazardous organic compounds in urban municipal solid waste from a developing country. Journal of Hazardous Materials, 160, 213.Google Scholar
  193. Tamtam, F., Mercier, F., Le Bot, B., Eurin, J., Dinh, Q. T., Clement, M., & Chevreuil, M. (2008). Occurrence and fate of antibiotics in the Seine river in various hydrological conditions. Science of the Total Environment, 393, 84–95.Google Scholar
  194. Ternes, T. A., & Joss, A. (2006). Human pharmaceuticals, hormones and fragrances. New York: IWA Publishing.Google Scholar
  195. Ternes, T. A., Meisenheimer, M. M., Dowell, D., Sacher, F., Brauchg, H., Haist-Gulde, B., Preuss, G., Wilme, U., & Zulei-Seibert, N. (2002). Removal of pharmaceuticals during drinking water treatment. Environmental Science and Technology, 36, 3855–3863.Google Scholar
  196. Ternes, T. A., Joss, A., & Siegrist, H. (2004). Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology, 38, 392A.Google Scholar
  197. Thorpe, K. L., Cummings, R. I., Hutchinson, T. H., Scholze, M., Brighty, G., Sumpter, J. P., & Tyler, C. R. (2003). Relative Potencies and combination effects of steroidal estrogens in fish. Environmental Science and Technology, 37, 1142–1149.Google Scholar
  198. Tixier, C., Singer, H. P., Oellers, S., & Muller, S. R. (2003). Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environmental Science and Technology, 37, 1061–1068.Google Scholar
  199. Topp, E., Monteiro, S. C., Beck, A., Coelho, B. B., Boxall, A. B. A., Duenk, P. W., Kleywegt, S., Lapen, D. R., Payne, M., Sabourin, L., Li, H. X., & Metcalfe, C. D. (2008). Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Science of the Total Environment, 396, 52.Google Scholar
  200. Travison, T. G., Araujo, A. B., O’Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population level decline in serum testosterone levels in American men. Journal of Clinical Endocrinology and Metabolism, 92, 196–202.Google Scholar
  201. Trenholm, R. A., Vanderford, B. J., Holady, J. C., Rexing, D. J., & Snyder, S. A. (2006). Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere, 65, 1990–1998.Google Scholar
  202. Trussell, R. R. (2001). Endocrine disruptors and the water industry. Journal of American Water Works Association, 93, 58–65.Google Scholar
  203. Tsai, W.-T., Leeb, M.-K., Suc, T.-Y., & Yuan, M. C. (2009). Photodegradation of bisphenol-A in a batch TiO2 suspension reactor. Journal of Hazardous Materials, 168, 269–275.Google Scholar
  204. Verma, A., Kaur, H., & Dixit, D. (2013). Photocatalytic, Sonolytic and Sonophotocatalytic Degradation of 4-Chloro-2-Nitro Phenol. Archives of Environmental Protection., 39(2), 17–28.Google Scholar
  205. Vogel, J. M. (2004). Tunnel vision: The regulation of endocrine disruptors. Political Science, 37, 277–303.Google Scholar
  206. Vogna, D., Marotta, R., Andreozzi, R., Napolitano, A., & d’Ischia, M. (2004a). Kinetic and chemical assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine. Chemosphere, 54, 497–505.Google Scholar
  207. Vogna, D., Marotta, R., Napolitano, A., Andreozzi, R., & d’Ischia, M. (2004b). Advanced oxidation of the pharmaceutical drug diclofenac with UV/H2O2 and Ozone. Water Research, 38, 414–422.Google Scholar
  208. Vulliet, & Cren-Olivé, E. (2011). Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environmental Pollution, 159, 2929–2934.Google Scholar
  209. Writer, J. H., Barber, L. B., Brown, G. K., Taylor, H. E., Kiesling, R. L., Ferrey, M. L., Jahns, N. D., Bartell, S. E., & Schoenfuss, H. L. (2010). Anthropogenic tracers, endocrine disrupting chemicals, and endocrine disruption in Minnesota lakes. Science of the Total Environment, 409, 100–111.Google Scholar
  210. Wu, C. X., Witter, J. D., Spongberg, A. L., & Czajkowski, K. P. (2009). Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin. Water Research, 43, 3407–3416.Google Scholar
  211. Xia, K., Bhandari, A., Das, K., & Pillar, G. (2005). Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. Journal of Environmental Quality, 34, 91–104.Google Scholar
  212. Xiao, R., Diaz-Rivera, D., & Linda, K. (2013). Weaver factors influencing pharmaceutical and personal care product degradation in aqueous solution using pulsed wave ultrasound. Industrial and Engineering Chemistry Research, 52, 2824–2831.Google Scholar
  213. Xu, B., Gao, N. Y., Rui, M., Wang, H., & Wu, H. H. (2007). Degradation of endocrine disruptor bisphenol A in drinking water by ozone oxidation. Journal of Hazardous Materials, 138, 526–533.Google Scholar
  214. Xu, J., Wu, L., Chen, W., & Chang, A. C. (2008). Simultaneous determination of pharmaceuticals, endocrine disrupting compounds and hormone in solids by gas chromatography–mass spectrometry. J. Chromatog., A, 1212, 189.Google Scholar
  215. Xue, N., & Xu, X. (2006). Composition, distribution and characterization of suspected endocrine-disrupting pesticides in Beying GuanTing Reservoir (GTR). Archives of Environmental Contamination and Toxicology, 50, 463–473.Google Scholar
  216. Yang, L., Yu, L. E., & Ray, M. B. (2008). Degradation of paracetamol in aqueous solutions by TiO2 photocatalysis. Water Research, 42, 3480–3488.Google Scholar
  217. Yao, S., Li, J., & Shi, Z. (2010). Immobilization of TiO2 nanoparticles on activated carbon fiber and its photodegradation performance for organic pollutants. Particuology, 8, 272–278.Google Scholar
  218. Yin, H. S., Zhou, Y., & Ai, S. Y. (2009). Preparation and characteristic of cobalt phthalocyanine modified carbon paste electrode for bisphenol A detection. J. Electroanalytical Chem., 626(1–2), 80–88.Google Scholar
  219. Yoon, Y., & Lueptow, R. M. (2005). Removal of organic contaminants by RO and NF membranes. J. Membrane Sci., 261, 76–86.Google Scholar
  220. Yoon, Y., Westerhoff, P., Synder, S. A., & Wert, E. C. (2006a). Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membrane Sci., 270, 88–100.Google Scholar
  221. Yoon, Y., Westerhoff, P., Synder, S. A., Wert, E. C., & Yoon, J. (2006b). Removal of endocrine disrupting compounds by nanofiltration and ultrafiltration membranes. Desalination, 202, 16–23.Google Scholar
  222. Yoon, Y., Westerhoff, P., Snyder, S. A., Wert, E. C., & Yoon, J. (2007). Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination, 202(1–3), 16–23.Google Scholar
  223. Yu, C.-P., & Chu, K.-H. (2009). Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA. Chemosphere, 75, 1281–1286.Google Scholar
  224. Yu, Z. R., Peldszus, S., & Huck, P. M. (2008). Adsorption characteristics of selected pharmaceuticals and an endocrine disrupting compound – naproxen, carbamazepine and nonylphenol – on activated carbon. Water Research, 42(12), 2873–2882.Google Scholar
  225. Yurdakal, S., Loddo, V., Augugliaro, V., Berber, H., Palmisano, G., & Palmisano, L. (2007). Photodegradation of pharmaceutical drugs in aqueous TiO2 suspensions: Mechanism and kinetics. Catalysis Today, 129, 9–15.Google Scholar
  226. Zala, S. M., & Penn, D. J. (2004). Abnormal behaviours induced by chemical pollution: A review of the evidence and new challenges. Animal Behaviour, 68, 649–664.Google Scholar
  227. Zelmanov, G., & Semiat, R. (2008). Iron(3) oxide-based nanoparticles as catalysts in advanced organic aqueous oxidation. Water Research, 42, 492–498.Google Scholar
  228. Zeng, Z.-Q., Wang, J.-F., Li, Z.-H., Sun, B.-C., Shao, L., Li, W.-J., Chen, J.-F., & Zou, H.-K. (2013). The advanced oxidation process of phenol solution by O3/H2O2 in a rotating packed bed. Ozone: Science & Engineering, 35, 101–108.Google Scholar
  229. Zhang, Y., & Zhou, J. L. (2008). Occurrence and removal of endocrine disrupting chemicals in wastewater treatment. Chemosphere, 73, 848–853.Google Scholar
  230. Zhang, W., Li, Y., Qianyuan, W., & Hongying, H. (2010). Removal of endocrine-disrupting compounds, estrogenic activity, and Escherichia coliform from secondary effluents in a TiO2-Coated photocatalytic reactor. Environmental Engineering Science, 29(3), 196–201.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Jimoh O. Tijani
    • 1
  • Ojo O. Fatoba
    • 1
  • Leslie. F. Petrik
    • 1
  1. 1.Environmental and Nano Sciences Group, Department of ChemistryUniversity of the Western CapeBellvilleSouth Africa

Personalised recommendations